The value of Ki67 has been suggested in some studies and a meta-analysis confirmed that a high baseline Ki67 predicts a higher probability of pCR irrespectively other variables, even in ER + breast cancer [37]. This evidence concerns the gene MKI67 and breast carcinoma.